STOCK TITAN

[D] OmniAb, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
D

OmniAb, Inc. (OABI) filed a Form D reporting a completed private equity offering under Rule 506(b). The filing states a total offering amount of $29,998,991, with $29,998,991 sold and . The first sale date is listed as 2025-08-26. The issuer identifies itself as a Delaware corporation formed in 2022, headquartered at 5980 Horton Street, Suite 600, Emeryville, CA. The offering involved 15 investors, listed equity securities only, and reports sales commissions of $1,799,939 (estimate). The filing indicates $0 of proceeds were used to pay named executive officers, directors or promoters.

OmniAb, Inc. (OABI) ha depositato un Modulo D segnalando un'offerta privata completata ai sensi della Regola 506(b). La comunicazione riporta un ammontare totale dell'offerta di $29.998.991, con $29.998.991 venduti e $0 rimanenti da vendere. La prima data di vendita è indicata come 2025-08-26. L'emittente si identifica come una società del Delaware costituita nel 2022, con sede in 5980 Horton Street, Suite 600, Emeryville, CA. L'offerta ha coinvolto 15 investitori, ha riguardato soltanto titoli di capitale e segnala commissioni di vendita per $1.799.939 (stima). Il deposito indica che $0 dei proventi è stato utilizzato per pagare dirigenti esecutivi nominati, amministratori o promotori.

OmniAb, Inc. (OABI) presentó un Formulario D informando sobre una oferta privada completada conforme a la Regla 506(b). El informe indica un monto total de la oferta de $29.998.991, con $29.998.991 vendidos y $0 restantes por vender. La fecha de la primera venta figura como 2025-08-26. El emisor se identifica como una corporación de Delaware constituida en 2022, con sede en 5980 Horton Street, Suite 600, Emeryville, CA. La oferta involucró a 15 inversores, solo incluyó valores de capital y reporta comisiones de ventas por $1.799.939 (estimado). El formulario indica que $0 de los ingresos se usaron para pagar a ejecutivos nombrados, directores o promotores.

OmniAb, Inc. (OABI)는 규칙 506(b)에 따른 완료된 사모(프라이빗) 오퍼링을 보고하는 Form D를 제출했습니다. 제출서에는 총 오퍼링 금액이 $29,998,991로 기재되어 있으며, $29,998,991가 판매됨판매 잔액 $0으로 보고되어 있습니다. 최초 판매일은 2025-08-26로 표기되어 있습니다. 발행인은 2022년에 설립된 델라웨어 법인으로 자신을 밝히며 본사는 5980 Horton Street, Suite 600, Emeryville, CA에 있습니다. 해당 오퍼링에는 15명의 투자자가 참여했으며, 주식 증권(지분)만 포함되었고 판매 수수료는 $1,799,939(추정)로 보고되어 있습니다. 제출서에는 명시된 최고경영진, 이사 또는 프로모터에게 지급된 수익은 $0로 기재되어 있습니다.

OmniAb, Inc. (OABI) a déposé un formulaire D signalant une offre privée achevée en vertu de la règle 506(b). Le dossier indique un montant total de l'offre de 29 998 991 $, dont 29 998 991 $ vendus et 0 $ restant à vendre. La date de première vente est indiquée comme 2025-08-26. L'émetteur se présente comme une société du Delaware créée en 2022, dont le siège est situé au 5980 Horton Street, Suite 600, Emeryville, CA. L'offre a impliqué 15 investisseurs, portait uniquement sur des valeurs mobilières de capital et signale des commissions de vente de 1 799 939 $ (estimation). Le dossier indique que 0 $ des produits ont été utilisés pour rémunérer des dirigeants nommés, des administrateurs ou des promoteurs.

OmniAb, Inc. (OABI) hat ein Formular D eingereicht und eine abgeschlossene Private-Equity-Angebotsmeldung gemäß Regel 506(b) gemeldet. Die Einreichung nennt einen Gesamtangebotbetrag von $29.998.991, davon sind $29.998.991 verkauft und $0 verbleiben zum Verkauf. Das Datum des ersten Verkaufs ist mit 2025-08-26 angegeben. Der Emittent gibt an, eine in 2022 gegründete Delaware-Gesellschaft zu sein, mit Sitz in 5980 Horton Street, Suite 600, Emeryville, CA. Das Angebot umfasste 15 Investoren, bezog sich ausschließlich auf Eigenkapitalwerte und weist Verkaufsprovisionen in Höhe von $1.799.939 (Schätzung) aus. In der Einreichung wird angegeben, dass $0 der Erlöse zur Bezahlung benannter Führungskräfte, Direktoren oder Promoter verwendet wurden.

Positive
  • Offering fully subscribed: Total offering amount of $29,998,991 is reported as sold with $0 remaining
  • Exemption claimed: Reliance on Rule 506(b), indicating accredited-investor reliance and no general solicitation
  • No insider payments: Filing reports $0 of offering proceeds used to pay named officers, directors, or promoters
Negative
  • High sales commissions: Reported estimated sales commissions of $1,799,939
  • Concentrated investor base: Only 15 investors participated, indicating potential ownership concentration

Insights

TL;DR: Routine private equity raise completed under Rule 506(b) with concentrated investor base and sizable commissions.

The Form D shows OmniAb completed an equity offering totaling $29,998,991 with all securities sold as of the first sale date 2025-08-26. The offering was conducted under Rule 506(b), indicating reliance on accredited investor exemptions and limiting general solicitation. Fifteen investors participated, which is a relatively small investor count for the aggregate size and may indicate concentration of ownership. Reported sales commissions of $1,799,939 are material in absolute terms and should be monitored when assessing net proceeds available for corporate purposes. The filer also certifies no payments to named insiders from offering proceeds.

TL;DR: Filing appears to be a standard Form D notice relying on Rule 506(b) with required disclosures completed.

OmniAb's Form D identifies the issuer, jurisdiction (Delaware), formation year (2022), principal address, and related persons. The issuer checked No for use in a business combination and indicated the offering duration is less than one year. The disclosure that $0 of proceeds were used to pay officers, directors or promoters addresses a common SEC disclosure item. As a regulatory notice, the filing provides the basic information states require under NSMIA while asserting the issuer is not disqualified from relying on the claimed exemption.

OmniAb, Inc. (OABI) ha depositato un Modulo D segnalando un'offerta privata completata ai sensi della Regola 506(b). La comunicazione riporta un ammontare totale dell'offerta di $29.998.991, con $29.998.991 venduti e $0 rimanenti da vendere. La prima data di vendita è indicata come 2025-08-26. L'emittente si identifica come una società del Delaware costituita nel 2022, con sede in 5980 Horton Street, Suite 600, Emeryville, CA. L'offerta ha coinvolto 15 investitori, ha riguardato soltanto titoli di capitale e segnala commissioni di vendita per $1.799.939 (stima). Il deposito indica che $0 dei proventi è stato utilizzato per pagare dirigenti esecutivi nominati, amministratori o promotori.

OmniAb, Inc. (OABI) presentó un Formulario D informando sobre una oferta privada completada conforme a la Regla 506(b). El informe indica un monto total de la oferta de $29.998.991, con $29.998.991 vendidos y $0 restantes por vender. La fecha de la primera venta figura como 2025-08-26. El emisor se identifica como una corporación de Delaware constituida en 2022, con sede en 5980 Horton Street, Suite 600, Emeryville, CA. La oferta involucró a 15 inversores, solo incluyó valores de capital y reporta comisiones de ventas por $1.799.939 (estimado). El formulario indica que $0 de los ingresos se usaron para pagar a ejecutivos nombrados, directores o promotores.

OmniAb, Inc. (OABI)는 규칙 506(b)에 따른 완료된 사모(프라이빗) 오퍼링을 보고하는 Form D를 제출했습니다. 제출서에는 총 오퍼링 금액이 $29,998,991로 기재되어 있으며, $29,998,991가 판매됨판매 잔액 $0으로 보고되어 있습니다. 최초 판매일은 2025-08-26로 표기되어 있습니다. 발행인은 2022년에 설립된 델라웨어 법인으로 자신을 밝히며 본사는 5980 Horton Street, Suite 600, Emeryville, CA에 있습니다. 해당 오퍼링에는 15명의 투자자가 참여했으며, 주식 증권(지분)만 포함되었고 판매 수수료는 $1,799,939(추정)로 보고되어 있습니다. 제출서에는 명시된 최고경영진, 이사 또는 프로모터에게 지급된 수익은 $0로 기재되어 있습니다.

OmniAb, Inc. (OABI) a déposé un formulaire D signalant une offre privée achevée en vertu de la règle 506(b). Le dossier indique un montant total de l'offre de 29 998 991 $, dont 29 998 991 $ vendus et 0 $ restant à vendre. La date de première vente est indiquée comme 2025-08-26. L'émetteur se présente comme une société du Delaware créée en 2022, dont le siège est situé au 5980 Horton Street, Suite 600, Emeryville, CA. L'offre a impliqué 15 investisseurs, portait uniquement sur des valeurs mobilières de capital et signale des commissions de vente de 1 799 939 $ (estimation). Le dossier indique que 0 $ des produits ont été utilisés pour rémunérer des dirigeants nommés, des administrateurs ou des promoteurs.

OmniAb, Inc. (OABI) hat ein Formular D eingereicht und eine abgeschlossene Private-Equity-Angebotsmeldung gemäß Regel 506(b) gemeldet. Die Einreichung nennt einen Gesamtangebotbetrag von $29.998.991, davon sind $29.998.991 verkauft und $0 verbleiben zum Verkauf. Das Datum des ersten Verkaufs ist mit 2025-08-26 angegeben. Der Emittent gibt an, eine in 2022 gegründete Delaware-Gesellschaft zu sein, mit Sitz in 5980 Horton Street, Suite 600, Emeryville, CA. Das Angebot umfasste 15 Investoren, bezog sich ausschließlich auf Eigenkapitalwerte und weist Verkaufsprovisionen in Höhe von $1.799.939 (Schätzung) aus. In der Einreichung wird angegeben, dass $0 der Erlöse zur Bezahlung benannter Führungskräfte, Direktoren oder Promoter verwendet wurden.

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM D

Notice of Exempt Offering of Securities

OMB APPROVAL
OMB Number: 3235-0076
Estimated average burden
hours per response: 4.00

1. Issuer's Identity

CIK (Filer ID Number) Previous Names
None
Entity Type
0001846253
Avista Public Acquisition Corp. II
X Corporation
Limited Partnership
Limited Liability Company
General Partnership
Business Trust
Other (Specify)

Name of Issuer
OmniAb, Inc.
Jurisdiction of Incorporation/Organization
DELAWARE
Year of Incorporation/Organization
Over Five Years Ago
X Within Last Five Years (Specify Year) 2022
Yet to Be Formed

2. Principal Place of Business and Contact Information

Name of Issuer
OmniAb, Inc.
Street Address 1 Street Address 2
5980 HORTON STREET SUITE 600
City State/Province/Country ZIP/PostalCode Phone Number of Issuer
EMERYVILLE CALIFORNIA 94608 510-250-7800

3. Related Persons

Last Name First Name Middle Name
Foehr Matthew W.
Street Address 1 Street Address 2
5980 Horton Street, Suite 600
City State/Province/Country ZIP/PostalCode
Emeryville CALIFORNIA 94608
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Gustafson Kurt
Street Address 1 Street Address 2
5980 Horton Street, Suite 600
City State/Province/Country ZIP/PostalCode
Emeryville CALIFORNIA 94608
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Berkman Charles
Street Address 1 Street Address 2
5980 Horton Street, Suite 600
City State/Province/Country ZIP/PostalCode
Emeryville CALIFORNIA 94608
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Higgins John
Street Address 1 Street Address 2
5980 Horton Street, Suite 600
City State/Province/Country ZIP/PostalCode
Emeryville CALIFORNIA 94608
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Cochran Jennifer
Street Address 1 Street Address 2
5980 Horton Street, Suite 600
City State/Province/Country ZIP/PostalCode
Emeryville CALIFORNIA 94608
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Bertozzi Carolyn R.
Street Address 1 Street Address 2
5980 Horton Street, Suite 600
City State/Province/Country ZIP/PostalCode
Emeryville CALIFORNIA 94608
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Love Steve
Street Address 1 Street Address 2
5980 Horton Street, Suite 600
City State/Province/Country ZIP/PostalCode
Emeryville CALIFORNIA 94608
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Crouse Steve
Street Address 1 Street Address 2
5980 Horton Street, Suite 600
City State/Province/Country ZIP/PostalCode
Emeryville CALIFORNIA 94608
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Gotwals Philip J.
Street Address 1 Street Address 2
5980 Horton Street, Suite 600
City State/Province/Country ZIP/PostalCode
Emeryville CALIFORNIA 94608
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


4. Industry Group

Agriculture
Banking & Financial Services
Commercial Banking
Insurance
Investing
Investment Banking
Pooled Investment Fund
Is the issuer registered as
an investment company under
the Investment Company
Act of 1940?
Yes No
Other Banking & Financial Services
Business Services
Energy
Coal Mining
Electric Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other Energy
Health Care
X Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
Commercial
Construction
REITS & Finance
Residential
Other Real Estate
Retailing
Restaurants
Technology
Computers
Telecommunications
Other Technology
Travel
Airlines & Airports
Lodging & Conventions
Tourism & Travel Services
Other Travel
Other

5. Issuer Size

Revenue Range OR Aggregate Net Asset Value Range
No Revenues No Aggregate Net Asset Value
$1 - $1,000,000 $1 - $5,000,000
$1,000,001 - $5,000,000 $5,000,001 - $25,000,000
$5,000,001 - $25,000,000 $25,000,001 - $50,000,000
$25,000,001 - $100,000,000 $50,000,001 - $100,000,000
Over $100,000,000 Over $100,000,000
X Decline to Disclose Decline to Disclose
Not Applicable Not Applicable

6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

Rule 504(b)(1) (not (i), (ii) or (iii))
Rule 504 (b)(1)(i)
Rule 504 (b)(1)(ii)
Rule 504 (b)(1)(iii)
X Rule 506(b)
Rule 506(c)
Securities Act Section 4(a)(5)
Investment Company Act Section 3(c)
Section 3(c)(1) Section 3(c)(9)
Section 3(c)(2) Section 3(c)(10)
Section 3(c)(3) Section 3(c)(11)
Section 3(c)(4) Section 3(c)(12)
Section 3(c)(5) Section 3(c)(13)
Section 3(c)(6) Section 3(c)(14)
Section 3(c)(7)

7. Type of Filing

X New Notice Date of First Sale 2025-08-26 First Sale Yet to Occur
Amendment

8. Duration of Offering

Does the Issuer intend this offering to last more than one year?
Yes X No

9. Type(s) of Securities Offered (select all that apply)

X Equity Pooled Investment Fund Interests
Debt Tenant-in-Common Securities
Option, Warrant or Other Right to Acquire Another Security Mineral Property Securities
Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe)

10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
Yes X No

Clarification of Response (if Necessary):

11. Minimum Investment

Minimum investment accepted from any outside investor $0 USD

12. Sales Compensation

Recipient
Recipient CRD Number None
Leerink Partners LLC 39011
(Associated) Broker or Dealer X None
(Associated) Broker or Dealer CRD Number X None
None None
Street Address 1 Street Address 2
53 State Street, 40th Floor
City State/Province/Country ZIP/Postal Code
Boston MASSACHUSETTS 02109
State(s) of Solicitation (select all that apply)
Check "All States" or check individual States
X All States
Foreign/non-US

13. Offering and Sales Amounts

Total Offering Amount $29,998,991 USD
or Indefinite
Total Amount Sold $29,998,991 USD
Total Remaining to be Sold $0 USD
or Indefinite

Clarification of Response (if Necessary):

14. Investors

Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
15

15. Sales Commissions & Finder's Fees Expenses

Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

Sales Commissions $1,799,939 USD
Estimate
Finders' Fees $0 USD
Estimate

Clarification of Response (if Necessary):

16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

$0 USD
Estimate

Clarification of Response (if Necessary):

Signature and Submission

Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

Terms of Submission

In submitting this notice, each issuer named above is:
  • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
  • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of: (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
  • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

Issuer Signature Name of Signer Title Date
OmniAb, Inc. /s/ Charles Berkman Charles Berkman Secretary 2025-09-10

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

* This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


OmniAb, Inc.

NASDAQ:OABI

OABI Rankings

OABI Latest News

OABI Latest SEC Filings

OABI Stock Data

231.77M
109.89M
14.75%
58.72%
5.63%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
EMERYVILLE